Cargando…
Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: The primary objective of this study is to test the hypothesis that administration of dexamethasone 20 mg is superior to a 6 mg dose in adult patients with moderate or severe ARDS due to confirmed COVID-19. The secondary objective is to investigate the efficacy and safety of dexamethasone...
Autores principales: | Maláska, Jan, Stašek, Jan, Duška, František, Balík, Martin, Máca, Jan, Hruda, Jan, Vymazal, Tomáš, Klementová, Olga, Zatloukal, Jan, Gabrhelík, Tomáš, Novotný, Pavel, Demlová, Regina, Kubátová, Jana, Vinklerová, Jana, Svobodník, Adam, Kratochvíl, Milan, Klučka, Jozef, Gál, Roman, Singer, Mervyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917377/ https://www.ncbi.nlm.nih.gov/pubmed/33648568 http://dx.doi.org/10.1186/s13063-021-05116-9 |
Ejemplares similares
-
Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)—study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial
por: Maláska, Jan, et al.
Publicado: (2022) -
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU
por: Duška, František, et al.
Publicado: (2020) -
COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)
por: Musilová, Tereza, et al.
Publicado: (2023) -
Palliative care practice and moral distress during COVID-19 pandemic (PEOpLE-C19 study): a national, cross-sectional study in intensive care units in the Czech Republic
por: Prokopová, Tereza, et al.
Publicado: (2022) -
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
por: Stašek, Jan, et al.
Publicado: (2023)